1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014

  • September 2014
  • -
  • Business Monitor International
  • -
  • 93 pages

Includes 3 FREE quarterly updates

BMI View:
Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the
inherent difficulties of providing infrastructure and access to healthcare in such a large country. However, the government continues to show its commitment to improving healthcare as it allocates more funds to constructing new health clinics across the country. Although Kazakhstan's growing pharmaceutical industry will be driven by demand for generic medicines over the medium term, we believe that there are also significant opportunities for patented drug manufacturers as incomes rise and more advanced
treatments become available.

Headline Expenditure Projections
- Pharmaceuticals: KZT273.92bn (USD1.80bn) in 2013 to KZT335.18bn (USD1.84bn) in 2014; up 22.4% in local currency terms and 2.3% in US dollar terms.
- Healthcare: KZT1,487.03bn (USD9.77bn) in 2013 to KZT1,712.78bn (USD9.41bn) in 2014; +15.3% in local currency terms and -3.7% in US dollar terms.

Table Of Contents

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2014
BMI Industry View 7
SWOT .. 9
Industry Forecast .. 11
Pharmaceutical Market Forecast . 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kazakhstan 2010-2018) . . 12
Healthcare Market Forecast . 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2010-2018) . 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2010-2018) . . 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kazakhstan 2010-2018) . 16
Kazakhstan .. 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2010-2018) . 17
Patented Drug Market Forecast .. 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2010-2018) . . 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kazakhstan 2010-2018) . . 21
OTC Medicine Market Forecast .. 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kazakhstan 2010-2018) 23
Pharmaceutical Trade Forecast .. 24
Table: Pharmaceutical Trade Data And Forecasts (Kazakhstan 2012-2018) . 25
Table: Pharmaceutical Trade Data And Forecasts local currency (Kazakhstan 2012-2018) 25
Key Risks To BMI's Forecast Scenario 26
Macroeconomic Forecasts .. 27
Economic Analysis . 27
Industry Risk Reward Ratings 31
Central And Eastern Europe Risk/Reward Ratings .. 31
Kazakhstan Risk/Reward Ratings . 38
Rewards . 38
Risks 39
Market Overview 41
Industry Trends And Developments .. 43
Epidemiology 43
Healthcare Sector 44
Healthcare Sector Financing .. 46
Domestic Pharmaceutical Industry 47
Wholesale And Retail 51
Foreign Pharmaceutical Industry .. 52
Clinical Trials .. 54
Regulatory Development .. 56
Intellectual Property Environment . 58
Pricing And Reimbursement Regime . 59
Competitive Landscape . 63
Company Profile . 66
Chimpharm . 66
Romat .. 68
Novartis 70
Sanofi 72
GlaxoSmithKline 74
Nycomed .. 76
Merck and Co. 78
Pfizer 79
Ranbaxy 81
Demographic Forecast .. 83
Table: Kazakhstan's Population By Age Group, 1990-2020 ('000) 84
Table: Kazakhstan's Population By Age Group, 1990-2020 (% of total) 85
Table: Kazakhstan's Key Population Ratios, 1990-2020 . 86
Table: Kazakhstan's Rural And Urban Population, 1990-2020 . 86
Glossary .. 87
Methodology . 89
Pharmaceutical Expenditure Forecast Model . 89
Healthcare Expenditure Forecast Model .. 89
Notes On Methodology . 90
Risk/Reward Ratings Methodology 91
Ratings Overview . 92
Table: Pharmaceutical Risk/Reward Ratings Indicators . . 92
Indicator Weightings 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.